You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Medulloblastoma Sonic Hedgehog subgroup 1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting
  • Brain Tumor
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 20, 2022

Medulloblastoma Trial in Memphis (procedure, drug, radiation)

Recruiting
  • Medulloblastoma
  • Surgical resection
  • +11 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Sep 16, 2022

Basal Cell Carcinoma, Radiotherapy; Complications Trial (radiation, other, drug)

Not yet recruiting
  • Basal Cell Carcinoma
  • Radiotherapy; Complications
  • Radiotherapy
  • +2 more
  • (no location specified)
Sep 30, 2022

Medulloblastoma Trial in Worldwide (drug, other, radiation)

Recruiting
  • Medulloblastoma
  • Birmingham, Alabama
  • +192 more
Aug 17, 2022

Medulloblastoma Trial in Zürich (Sonidegib, Cisplatin, Lomustine)

Not yet recruiting
  • Medulloblastoma
  • Zürich, Switzerland
    University Hospital zurich
May 20, 2020

Untreated Childhood Medulloblastoma Trial in Worldwide (drug, radiation, other)

Active, not recruiting
Has Results
  • Untreated Childhood Medulloblastoma
  • Birmingham, Alabama
  • +177 more
Feb 25, 2022

Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma, Metastatic Basal Cell Carcinoma Trial in Netherlands (Vismodegib,

Recruiting
  • Basal Cell Carcinoma
  • +10 more
  • Nijmegen, Gelderland, Netherlands
  • +7 more
Jul 14, 2022

Medulloblastoma, WNT-activated Trial in Mumbai (Low dose Craniospinal Irradiation plus Focal Radiotherapy)

Recruiting
  • Medulloblastoma, WNT-activated
  • Low dose Craniospinal Irradiation plus Focal Radiotherapy
  • Mumbai, Maharashtra, India
    Tata Memorial Hospital
Oct 5, 2021

Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Bosutinib Monohydrate
  • +6 more
  • Duarte, California
    City of Hope Meidcal Center
Jun 7, 2022

Histologically Confirmed Medulloblastoma, Activation of the Sonic Hedgehog (SHH) Pathway Trial in Worldwide (vismodegib,

Terminated
  • Histologically Confirmed Medulloblastoma
  • Activation of the Sonic Hedgehog (SHH) Pathway
  • Marseille, Bouches Du Rhône, France
  • +14 more
May 20, 2019

Cerebellar Ataxia Trial in Giza (motor imaginary training, physical therapy training)

Completed
  • Cerebellar Ataxia
  • motor imaginary training
  • physical therapy training
  • Giza, Egypt
    Reham Alsakhawi
Aug 7, 2023

Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)

Active, not recruiting
Has Results
  • Brain and Central Nervous System Tumors
  • Induction Chemotherapy
  • +3 more
  • Palo Alto, California
  • +5 more
Nov 29, 2022

A Study of the Genetic Analysis of Brain Disorders

Completed
  • Holoprosencephaly
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 10, 2021

    Coronary Calcified Disease Trial in China (Pulsed Sonic Balloon Dilatation Catheter and Pulsed Sonic Generater)

    Enrolling by invitation
    • Coronary Calcified Disease
    • Pulsed Sonic Balloon Dilatation Catheter and Pulsed Sonic Generater
    • Beijing, Beijing, China
    • +13 more
    Jun 1, 2022

    Based on Molecular Typing of Medulloblastoma in Children

    Not yet recruiting
    • Medulloblastoma, Childhood
    • Prospective observational study, no intervention
    • (no location specified)
    Jun 4, 2022

    Dementia, Behavioural and Psychiatric Symptoms of Dementia Trial in Toronto (Acusticare, Treatment as usual)

    Completed
    • Dementia
    • Behavioural and Psychiatric Symptoms of Dementia
    • Acusticare
    • Treatment as usual
    • Toronto, Ontario, Canada
      Toronto Rehabilitation Institute, University Health Network
    Oct 12, 2022

    Medulloblastoma Trial (drug, other, radiation)

    Recruiting
    • Medulloblastoma
    • Madera, California
    • +1 more
    Jan 30, 2023

    Asymptomatic Condition Trial (muscle streching exercice, Slider, Tensioner)

    Not yet recruiting
    • Asymptomatic Condition
    • muscle streching exercice
    • +2 more
    • (no location specified)
    Jun 1, 2023

    CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)

    Active, not recruiting
    Has Results
    • Central Nervous System Neoplasms
    • Medulloblastoma
    • Stanford, California
    • +24 more
    Sep 28, 2022

    Basal Cell Carcinoma Trial in Zürich (Cemiplimab Injection [Libtayo])

    Recruiting
    • Basal Cell Carcinoma
    • Cemiplimab Injection [Libtayo]
    • Zürich, Switzerland
      University Hospital Zurich, Clinic of Dermatology
    Nov 3, 2022

    Neuroblastoma, Medulloblastoma Trial in United States (Nifurtimox, Cyclophosphamide, Topotecan)

    Completed
    Has Results
    • Neuroblastoma
    • Medulloblastoma
    • San Diego, California
    • +14 more
    Dec 28, 2022

    Toothbrushes on Plaque Removal and Gingival Health

    Completed
    • Gingivitis
    • Dental Plaque
    • Oscillating-rotating electric toothbrush
    • +2 more
    • Cincinnati, Ohio
      Multiple Study Locations
    Oct 21, 2022

    Plaque Induced Gingivitis Trial in Fort Wayne (Power sonic toothbrush, Manual toothbrush)

    Completed
    • Plaque Induced Gingivitis
    • Power sonic toothbrush
    • Manual toothbrush
    • Fort Wayne, Indiana
      Timber Falls Dental Research
    Nov 6, 2023

    Plaque Induced Gingivitis Trial in Fort Wayne (U-shaped Power Toothbrush, Soft Manual Toothbrush)

    Completed
    • Plaque Induced Gingivitis
    • U-shaped Power Toothbrush
    • Soft Manual Toothbrush
    • Fort Wayne, Indiana
      Salus Research, Inc
    Nov 5, 2023

    Rare CNS Tumors Outcomes &Risk

    Recruiting
    • High Grade Meningioma
    • +4 more
      • Bethesda, Maryland
        National Cancer Institute (NCI)
      Jul 6, 2022